Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2024-11-20
2025-05-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility Study of a Non-invasive Device to Quickly, Easily and Accurately Measure Respiration in a Clinical Setting
NCT04182711
Optimized Single-breath Helium Lung Volume in Obstructive Lung Disease
NCT04919200
Intrinsic PEEP and Laryngeal Aperture in COPD
NCT02437630
Efficacy and Mechanism of NIV in Relieving Dyspnea After Exercise in Patients With Stable Severe COPD
NCT03568747
Mathematical Analysis of Signals and Clinical Parameters Provided by Non-invasive Home Ventilation Devices
NCT07267104
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Potential participants will be identified when they are booking into their clinic appointment. All patients will be attending PFT clinic as part of their clinical care; none will be attending as part of the study only. Patients will be asked if they would like to participate in the study after receiving the patient information leaflet and given time to ask any questions. The investigators aim to recruit 50 patients. This was deemed a suitable number to be able to undertake machine learning analysis with sufficient data. The investigators aim to recruit these 50 patients by attending PFT clinic weekly for approximately 3 months. They will vary the days of the week/clinic times they attend to gain a range of different patient groups as PFT clinics vary across the week.
After participants are fully consented, baseline data will be collected. This will involve a medical questionnaire that they will be asked to complete. The following data will be collected using the questionnaire:
Patient demographics: Age, sex, height, weight Comorbidities including past medical and surgical history Smoking status Alcohol status Current medications used Allergy status Reason for spirometry testing
Once the questionnaire is completed the participants will start the measurement section of the study. They will have two respiratory measurement devices attached. The Go Direct Respiration Sensor and a biosignal respiratory belts will both be fitted over light clothing so that participants will wear both sensors at once. They work in different ways but both use chest movement during breathing to determine respiratory effort and respiratory rate. They fit as bands around the chest. The investigators will aim to place the devices in similar positions in all participants (around the centre of the chest at the breast bone). Before confirming their placement, participants will be asked if the devices are comfortable and allow for normal breathing. These devices will track chest movement for the duration of the spirometry test and during timed activities of sitting, speaking, and walking. Once fitted, participants will continue with their spirometry appointment as planned. Some results from their spirometry testing will be noted in a secure database. This will include their inspiratory reserve volume, expiratory reserve volume, tidal volume and forced expiratory volume. The values alone will be recorded with no other patient data from the clinic appointment. At the end of the appointment, once they are back at baseline breathing, participants will be asked to read a short standardised script (in the form of a simple poem) over the course of 1-2 minutes that will allow us to analyse breathing patterns during speech. This will be coordinated with audio recordings of the speech which will be used in later data analysis of speech breathing. This may occur in the clinic room or another quiet room opposite the clinic depending on clinic timings. The final task before removal of the devices will be a short walk down the corridor outside of the clinical room to assess breathing during light exercise. This will be a set distance of 75 meters and should take around 1 minute to complete. Variability in timing of the walk will be accepted due to different patient walking speeds. The total data collection will take approximately 30 minutes. There should not be any additional clinic time required as the speech assessment and walking assessment can be undertaken outside of the clinic room. When the devices are removed, participants will be asked if they wish to comment on anything they felt during the study including discomfort from wearing the devices. The spirometry data will be collected by the PFT team as part of their routine testing and as such should not be influenced by the study. The researcher will not be involved in the spirometry testing portion of the study and therefore should not bias any results obtained.
Once the bands are removed the data will be downloaded onto a secure laptop with all patient identifying information removed. Following the collection of data for all 50 patients, the investigators aim to spend a further 1-2 months analysing the data and comparing it to the spirometry results. The final report will be available within 24 months of the study start date.
There will not be any planned interim analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients undergoing planned pulmonary function testing
Participants will be recruited from patients attending a planned pulmonary function clinic appointment.
They will be invited to participate when they are booking into clinic. Should they agree to participate the will have the following interventions:
1. Basic medical questionnaire
2. 2x chest band devices fitted over clothing They will then undertake their planned clinic appointment. No additional resources will be required for this.
Once they have finished their clinic appointment, the investigators will ask them to read a short script whilst recording their speech. Following this the investigators will ask them to walk 75m down the hall. The devices will then be removed and the study time is over.
Respiratory monitoring band
The only intervention in this study is the application of two CE marked study approved chest bands- the Go direct respiratory sensor and a biosignal respiration belt
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Respiratory monitoring band
The only intervention in this study is the application of two CE marked study approved chest bands- the Go direct respiratory sensor and a biosignal respiration belt
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gender: Any
* Aged 18 years and over.
* Able to give informed consent in English.
* Physically able to take part including a simple walking exercise
* Either in a asymptomatic participant group or planned for spirometry testing
Exclusion Criteria
* Pregnant
* Unable/uncomfortable to use a chest belt device for any reason.
* Patients \<18 years old
* Unable to read and speak in English to an understandable level
* Unable to walk (aided or unaided) for 1 minute
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Southampton
OTHER
University Hospital Southampton NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PFT
Southampton, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mateu-Mateus, M., et al., Camera-Based Method for Respiratory Rhythm Extraction From a Lateral Perspective. IEEE Access, 2020. 8: p. 154924-154939.
Lin, Y.-A., et al., Respiration Monitoring using a Motion Tape Chest Band and Portable Wireless Sensing Node. Journal of Commercial Biotechnology, 2022. 27.
Ross R, Mongan WM, O'Neill P, Rasheed I, Fontecchio A, Dion G, Dandekar KR. An Adaptively Parameterized Algorithm Estimating Respiratory Rate from a Passive Wearable RFID Smart Garment. Proc COMPSAC. 2021 Jul;2021:774-784. doi: 10.1109/COMPSAC51774.2021.00110. Epub 2021 Sep 9.
Vitazkova D, Foltan E, Kosnacova H, Micjan M, Donoval M, Kuzma A, Kopani M, Vavrinsky E. Advances in Respiratory Monitoring: A Comprehensive Review of Wearable and Remote Technologies. Biosensors (Basel). 2024 Feb 6;14(2):90. doi: 10.3390/bios14020090.
Brochard L, Martin GS, Blanch L, Pelosi P, Belda FJ, Jubran A, Gattinoni L, Mancebo J, Ranieri VM, Richard JC, Gommers D, Vieillard-Baron A, Pesenti A, Jaber S, Stenqvist O, Vincent JL. Clinical review: Respiratory monitoring in the ICU - a consensus of 16. Crit Care. 2012 Dec 12;16(2):219. doi: 10.1186/cc11146.
Pierce R. Spirometry: an essential clinical measurement. Aust Fam Physician. 2005 Jul;34(7):535-9.
Flesch JD, Dine CJ. Lung volumes: measurement, clinical use, and coding. Chest. 2012 Aug;142(2):506-510. doi: 10.1378/chest.11-2964.
Bhakta NR, McGowan A, Ramsey KA, Borg B, Kivastik J, Knight SL, Sylvester K, Burgos F, Swenson ER, McCarthy K, Cooper BG, Garcia-Rio F, Skloot G, McCormack M, Mottram C, Irvin CG, Steenbruggen I, Coates AL, Kaminsky DA. European Respiratory Society/American Thoracic Society technical statement: standardisation of the measurement of lung volumes, 2023 update. Eur Respir J. 2023 Oct 12;62(4):2201519. doi: 10.1183/13993003.01519-2022. Print 2023 Oct.
Related Links
Access external resources that provide additional context or updates about the study.
Go direct respiration belt
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
349993
Identifier Type: REGISTRY
Identifier Source: secondary_id
RHM CRI0461
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.